Literature DB >> 3739225

Characterization of an adenovirus type 5 mutant carrying embedded inverted terminal repeats.

Y Haj-Ahmad, F L Graham.   

Abstract

During construction of an adenovirus type 5 (Ad5) deletion mutant, dlE1,3, lacking E1 and E3 sequences, we isolated a variant, dlE1,3-1, which had a direct repeat of viral DNA terminal sequences attached to the left end of the genome. Analysis of this variant with restriction enzymes and by hybridization of Southern blots with specific probes indicated that the extra terminal segment contained the left 2.6% (920 bp) of Ad5 joined to 352 bp of pBR322 which in turn was linked to the left end (minus 21 bp) of dlE1,3. During replication of dlE1,3-1 the extra terminal segment was found to transfer to the right end of the genome resulting in a second variant, dlE1,3-2, with duplicated terminal sequences at both ends of the viral genome. DlE1,3-2 in turn was shown to revert back to dlE1,3-1 at high frequency. Although evidence was obtained indicating that the extra segment could be lost from the left end, spontaneous mutants which had lost direct repeats from both ends were never isolated. It was, however, possible to remove the extra terminal repeat of dlE1,3-1 by cleavage with a restriction enzyme and to isolate dlE1,3 containing wt termini. The rearrangements occurring during replication of dlE1,3-1 and dlE1,3-2 may be consequences of the mode of replication of Ad5 DNA and bear some resemblance to segment inversion in herpesviruses.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739225     DOI: 10.1016/0042-6822(86)90004-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  6 in total

1.  Selectivity of a replication-competent adenovirus for human breast carcinoma cells expressing the MUC1 antigen.

Authors:  T Kurihara; D E Brough; I Kovesdi; D W Kufe
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Assessment of hazard risk associated with the intravenous use of viral vectors in rodents.

Authors:  Jon D Reuter; Xiaoqun Fang; Christina S Ly; Karen K Suter; Daniel Gibbs
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

3.  Protein-primed DNA replication: role of inverted terminal repeats in the Escherichia coli bacteriophage PRD1 life cycle.

Authors:  H Savilahti; D H Bamford
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Adenoviruses with nonidentical terminal sequences are viable.

Authors:  R Lippé; F L Graham
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.

Authors:  L Chen; D Chen; Y Manome; Y Dong; H A Fine; D W Kufe
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 6.  Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer.

Authors:  Julia Reetz; Ottmar Herchenröder; Brigitte M Pützer
Journal:  Viruses       Date:  2014-04-02       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.